trials

Application

Magenta Therapeutics Highlights Recent Progress and Expected Timing of 2021 Milestones, Including Four Ongoing and Planned Clinical Trials

By Cheryl J. Morris 4 years ago

Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative

Application

Magenta Therapeutics Highlights Recent Progress and Expected Timing of 2021 Milestones, Including Four Ongoing and Planned Clinical Trials – Press Release

By Cheryl J. Morris 4 years ago

CAMBRIDGE, Mass.–(Business Wire)–Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring

Application

COVID-19 vaccine trials make development, but what does that indicate for you?

By Cheryl J. Morris 4 years ago

— FOR COVID-19. >> DID YOU Register On the internet? WILL YOU FILL OUT THIS